Document Detail


Timing of antibiotic prophylaxis in acute pancreatitis: a controlled randomized study with meropenem.
MedLine Citation:
PMID:  16771960     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Antibiotic prophylaxis improves the outcome of acute pancreatitis. Since bacterial translocation from the gut occurs in the first h of disease, early therapy is likely to achieve the maximal effect. The study compares early antibiotic treatment with treatment started after the demonstration of pancreatic necrosis. METHODS: Two hundred fifteen patients with pancreatitis were randomized to either group A (N=108), who started antibiotic therapy (meropenem 500 mg t.i.d.) at admission, or group B (N=107), who received antibiotics after the demonstration of necrosis at computed tomography (CT). CT was performed in both groups after at least 48 hr of hospitalization. The clinical course of disease was compared in the two groups. RESULTS: Thirty patients in group A and 29 in B showed necrosis on CT. The two groups were similar in demographics and characteristics of disease. Antibiotic treatment was started after 4.56+/-1.2 days from hospitalization in group B and after 1.07+/-0.6 days in A. Pancreatic infection occurred in four patients in group A (13.3%) and in nine in B (31%) (p=0.1). Extrapancreatic infection occurred in 16.6% of patients in group A and in 44.8% in B (p<0.05). Need for surgery and length of hospitalization were also higher in group B. Mortality rates were similar in the two groups, but, 3 of 4 patients with infected necrosis in group A and only 2 of 9 in group B died. CONCLUSIONS: Early antibiotic treatment is associated with a significant improvement in the prognosis of necrotizing acute pancreatitis (AP), because of a reduction in the occurrence of septic complications.
Authors:
Gianpiero Manes; Ilaria Uomo; Antonella Menchise; Pier Giorgio Rabitti; Elisa Chiara Ferrara; Generoso Uomo
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of gastroenterology     Volume:  101     ISSN:  0002-9270     ISO Abbreviation:  Am. J. Gastroenterol.     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-06-14     Completed Date:  2006-08-10     Revised Date:  2007-03-16    
Medline Journal Info:
Nlm Unique ID:  0421030     Medline TA:  Am J Gastroenterol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1348-53     Citation Subset:  IM    
Affiliation:
Department of Gastroenterology, L. Sacco University Hospital, Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antibiotic Prophylaxis*
Chi-Square Distribution
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Pancreatitis, Acute Necrotizing / drug therapy*,  radiography
Thienamycins / administration & dosage*
Tomography, X-Ray Computed
Treatment Outcome
Chemical
Reg. No./Substance:
0/Thienamycins; 96036-03-2/meropenem
Comments/Corrections
Comment In:
Am J Gastroenterol. 2007 Jan;102(1):208; author reply 208-9   [PMID:  17278269 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Temporal trend in relative risk of second primary colorectal cancer.
Next Document:  Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease.